2 results found.

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosi Clinical Trial using carfilzomib; romidepsin; laboratory biomarker analysis

Northwestern University - Recruiting 18 years or older.
- A Randomized Phase I Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma.
carfilzomib; romidepsin; laboratory biomarker analysis

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Cutaneou Clinical Trial using O6-benzylguanine; carmustine; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 19 years or older.
- Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma.
O6-benzylguanine; carmustine; laboratory biomarker analysis